variat
substitu
substitu
crystal
structur
indic
fit
benzyl
group
pocket
might
improv
amid
oxygen
warhead
accept
hbond
imidazol
complex
sarscov
pro
pro
oxyanionhol
amid
pro
benzyl
group
appear
fulli
embed
pocket
see
fig
c
therefor
replac
nbutyl
tabl
result
improv
inhibitori
activ
pro
wherea
enzym
somewhat
weaker
importantli
howev
compound
prove
total
inact
recombin
sarscov
pro
replac
substitu
tertbutyl
led
poor
activ
three
proteas
isobutyl
much
better
therefor
although
probabl
room
improv
decid
maintain
origin
design
benzyl
inspect
crystal
structur
complex
sarscov
pro
pro
suggest
interact
group
bind
cleft
might
suboptim
fig
c
order
furnish
group
flexibl
reduc
doubl
bond
gener
howev
presum
entrop
reason
led
decreas
activ
sarscov
pro
pro
compar
compound
tabl
pro
proteas
improv
reduct
doubl
bond
cinnamoyl
group
note
replicon
assay
compound
inferior
case
tabl
introduct
less
flexibl
bulki
substitu
b
b
also
met
limit
success
valu
mediocr
inhibit
pro
pro
higher
factor
least
inhibit
sarscov
pro
compar
compound
led
reduct
inhibitori
activ
particularli
pro
compound
benzo
b
inact
pro
moder
activ
pro
sarscov
pro
tabl
inspect
templat
crystal
structur
reveal
substitu
would
occupi
space
main
chain
peptid
substrat
partli
site
unabl
reach
space
normal
taken
aminoacid
sidechain
would
rel
unrestrict
three
proteas
howev
predict
mainchainlik
orient
extend
aromat
group
would
interfer
nh
group
carbonyl
summari
cinnamoyl
group
origin
compound
superior
substitu
explor
among
compound
test
thu
far
result
best
inhibitori
activ
toward
enteroviru
pro
sarscov
pro
accordingli
decid
retain
cinnamoyl
group
substitu
posit
ddd
j
hz
dd
j
hz
hrm
esi
mz
calcd
h
found
yield
h
nmr
mhz
dt
j
hz
hrm
esi
mz
calcd
h
found
yield
h
nmr
mhz
tdd
j
hz
ddd
j
hz
yield
h
nmr
mhz
dd
j
hz
